The United Kingdom (UK) has left the European Union (EU) and the transition period after Brexit comes to an end this year and from 1 January 2021 new regulations will apply. These changes will also affect the EU paediatric investigation plan (PIP) maintenance and procedures.

The UK competent authorities, the Medicines and Healthcare products Regulatory Agency (MHRA), recently published some preliminary guidance on the procedures and scenarios in the case of a no-deal Brexit with further guidance to follow. https://www.gov.uk/guidance/procedures-for-uk-pips-in-the-event-the-uk-leaves-the-eu-without-a-deal

Asphalion has already worked in more than 15 successful PIPs, so in case of any concerns related to paediatric development and PIPs, please contact us at info@asphalion.com.

Subscribirse al Directorio
Escribir un Artículo

Últimas Noticias

El diagnóstico genético neonatal mejor...

Un estudio con datos de los últimos 35 años, ind...

Más de 1.500 cambios epigenéticos en e...

Un equipo de investigadores de la Universidad Juli...

Tuneable reverse photochromes in the sol...

A new technique allows the design of solid materia...

Destacadas

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

En nuestro post hablamos sobre este interesante tipo de célula del si...

Un estudio de INCLIVA muestra el efecto ...

by INCLIVA

Han desarrollado un estudio para evaluar la correlación entre el teji...

Diapositiva de Fotos